Correlation Between Enzon Pharmaceuticals and Genenta Science
Can any of the company-specific risk be diversified away by investing in both Enzon Pharmaceuticals and Genenta Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzon Pharmaceuticals and Genenta Science into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzon Pharmaceuticals and Genenta Science SpA, you can compare the effects of market volatilities on Enzon Pharmaceuticals and Genenta Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzon Pharmaceuticals with a short position of Genenta Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzon Pharmaceuticals and Genenta Science.
Diversification Opportunities for Enzon Pharmaceuticals and Genenta Science
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Enzon and Genenta is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Enzon Pharmaceuticals and Genenta Science SpA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genenta Science SpA and Enzon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzon Pharmaceuticals are associated (or correlated) with Genenta Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genenta Science SpA has no effect on the direction of Enzon Pharmaceuticals i.e., Enzon Pharmaceuticals and Genenta Science go up and down completely randomly.
Pair Corralation between Enzon Pharmaceuticals and Genenta Science
If you would invest (100.00) in Enzon Pharmaceuticals on December 19, 2024 and sell it today you would earn a total of 100.00 from holding Enzon Pharmaceuticals or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Enzon Pharmaceuticals vs. Genenta Science SpA
Performance |
Timeline |
Enzon Pharmaceuticals |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Genenta Science SpA |
Enzon Pharmaceuticals and Genenta Science Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enzon Pharmaceuticals and Genenta Science
The main advantage of trading using opposite Enzon Pharmaceuticals and Genenta Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzon Pharmaceuticals position performs unexpectedly, Genenta Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genenta Science will offset losses from the drop in Genenta Science's long position.Enzon Pharmaceuticals vs. Pmv Pharmaceuticals | Enzon Pharmaceuticals vs. NewAmsterdam Pharma | Enzon Pharmaceuticals vs. Tempest Therapeutics | Enzon Pharmaceuticals vs. IO Biotech |
Genenta Science vs. Molecular Partners AG | Genenta Science vs. MediciNova | Genenta Science vs. Anebulo Pharmaceuticals | Genenta Science vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
CEOs Directory Screen CEOs from public companies around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |